(INNO) HERZLIYA, Israel and CALGARY, Alberta, Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release dated July 23, 2025, it will be consolidating all of its issued and...
HERZLIYA, Israel and CALGARY, AB, Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its...
PAINWeek is the premier US conference in pain management Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted HERZLIYA, Israel and CALGARY, AB, Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...
